ÊÝËØ/ÒÅ´«Ñ§,Leptin/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÚÐIJ¡,coronary heart diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʵÑéÑо¿,experimental studyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΣÏÕÒòËØ,Risk factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͳ¼Æ·ÖÎö,statistical analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÐ£ËÀ,acute myocardial infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©ÎïÁÆ·¨,Drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò»Ñõ»¯µªºÏø,nitric oxide synthaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²Ó¦ÓÃ,Clinical applicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆÀ¼ÛÖ¸±ê,evaluation indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅÁ½ðÉ­²¡,Parkinson's diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²·ÖÎö,clinical analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÆËã»ú¿ØÖÆ,Computer ControlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²¹Û²ì,Clinical observationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ï¥¹Ø½Ú,knee jointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×Áö»µËÀÒò×Ó-¦Á,tumor necrosis factor-¦ÁÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñü×µ,Lumbar vertebraeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­¸Éϸ°û,neural stem cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÐÔ³Õ´ô,Vascular dementiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔ¹£Èû,Cerebral infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÄÔ¹£ËÀ,Acute cerebral infarctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±íƤÉú³¤Òò×Ó,epidermal growth factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àà·çʪÐԹؽÚÑ×,rheumatoid arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÀÖÎ,controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à·¢ÐÔÓ²»¯,multiple sclerosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±×µ²¡,Cervical spondylosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔÐÔ̱»¾,cerebral palsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ÛÊöÎÄÏ×,review literatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±äÓ¦ÐÔ±ÇÑ×,allergic rhinitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔǰÁÐÏÙÑ×,Chronic prostatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹¦ÄÜÐÔÏû»¯²»Á¼,Functional dyspepsiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁòËáþ,magnesium sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èý²æÉñ¾­Í´,trigeminal neuralgiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²ÊÔÑé,clinical trialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡×ã,diabetic footÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔöÉúÐÔñ£ºÛ,Hypertrophic scarÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´´ÃæÓúºÏ,Wound healingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õë´ÌÁÆ·¨,Acupuncture therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔθÑ×,chronic gastritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú»îÖÊÁ¿,quality of lifeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÷ŹؽÚ,hip jointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡¶¾ÐÔ¸ÎÑ×,Viral hepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó¦ÓÃÑо¿,application researchÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÛѹ,intraocular pressureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²ÁÆÐ§,clinical effectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔ×èÈûÐԷβ¡,chronic obstructive pulmonary diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ø×´ðåÕî,Herpes zosterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²ÎÂó×¢ÉäÒº,Shenmai injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ê×¼Ìåϵ,standard systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾ÖÔîÐÔÄÔȱѪ,focal cerebral ischemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉË¿ÚÓúºÏ,wound healingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôм¤ËØÊÜÌå,progesterone receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç´Ì¼¤,Electrical stimulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« NKϸ°û,NK cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Î¸½×¢ÉäÒº,Shenfu injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ô¼ÁÐԹؽÚÑ×,adjuvant arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TÁܰÍϸ°ûÑÇȺ,T-lymphocyte subsetsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´Á÷ÐÔʳ¹ÜÑ×,Reflux esophagitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔÖ§Æø¹ÜÑ×,Chronic bronchitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç×Ó±Ç,Electronic noseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÐÑõÔ˶¯,aerobic exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔË®Ö×,Brain edemaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÄÒÂѳ²×ÛºÏÕ÷,Polycystic ovary syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õï¶ÏÏÔÏñ,diagnostic imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×µ¶¯Âö,Vertebral arteryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔçÆÚ¸ÉÔ¤,early interventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÂ黯¼î,Ephedrine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÄÀíÒòËØ,psychological factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹¬¾±ÃÓÀÃ,Cervical erosionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹Ü»îÐÔ³¦ëÄ,Vasoactive Intestinal PeptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èå¼ÒÎÄ»¯,Confucian cultureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θð¤Ä¤,gastric mucosaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐéÄâÈË,Virtual humanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θʳ¹Ü·´Á÷,gastroesophageal refluxÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔ¸ßѪѹ,essential hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´óÄÔÖж¯Âö,Middle cerebral arteryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔήËõÐÔθÑ×,chronic atrophic gastritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔȱѪÔÙ¹à×¢,Cerebral ischemia-reperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¹ËèÐ;±×µ²¡,Cervical spondylotic myelopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔÝ¡ÂéÕî,chronic urticariaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀÒ°±ËáôÇ»¯Ã¸,tyrosine hydroxylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²¾­Ñé,clinical experienceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θճĤ,gastric mucosaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ù´¡ÀíÂÛ,basic theoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÌÉ«Ïû·Ñ,green consumptionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Í·Õë,scalp acupunctureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÖÉ¢ÕÅÁ¿³ÉÏñ,Diffusion tensor imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´´ÉËÐÔÄÔËðÉË,Traumatic brain injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔȱÑõ,Cerebral anoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÄÚÆ¤Éú³¤Òò×ÓÀà,Vascular endothelial growth factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äæ×ªÂ¼¾ÛºÏøÁ´·´Ó¦,Reverse transcriptase polymerase chain reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ֪ʶ±í´ï,knowledge representationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔçÆÚ¿µ¸´,Early rehabilitationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÖÊõÆÚ¼ä,Intraoperative periodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆÀ¼Û·½·¨,evaluation methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ÌÔÝÐÔÄÔȱѪ·¢×÷,Transient ischemic attackÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔµ¨ÄÒÑ×,Acute cholecystitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪÁ÷ËÙ¶È,Blood flow velocityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êõºó²¢·¢Ö¢,postoperative complicationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­×èÖÍ,Nerve blockÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«